Gallium nitrate in advanced bladdercarcinoma: Southwest oncology group study

Urology

Volumn 38, Issue 4, 1991, Pages 355-357

  Crawford, E David ^a,b,c,d,e   Saiers, Joseph H ^a,b,c,d,e   Baker, Laurence H ^a,b,c,d,e   Costanzi, John H ^a,b,c,d,e   Bukowski, Ronald M ^a,b,c,d,e  

^a UNIVERSITY OF COLORADO   (United States)

^b VA Medical Center   (United States)

^c WAYNE STATE UNIVERSITY   (United States)

^d THOMPSON CANCER SURVIVAL CENTER   (United States)

^e LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GALLIUM NITRATE;

ADVANCED CANCER; ARTICLE; BLADDER CARCINOMA; CLINICAL ARTICLE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; NEPHROTOXICITY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; BLADDER NEOPLASMS; CARCINOMA, TRANSITIONAL CELL; DRUG ADMINISTRATION SCHEDULE; DRUG EVALUATION; GALLIUM; HUMAN; SUPPORT, U.S. GOV'T, P.H.S.; UREMIA;

EID: 0025935751     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/0090-4295(91)80152-W     Document Type: Article

References (7)

1. Chemotherapy of metastatic bladder cancer
2. Phase 1-11 clinical trial of gallium nitrate (NSC 15200)
3. Phase I study of gallium nitrate in patients with advanced cancer
4. Phase I clinical studies with gallium nitrate
5. Chemotherapy of bladder carcinoma
6. Treatment of patients with advanced malignant lymphoma using gallium nitrate administered as a seven-day continuous infusion